The fact that cardiovascular disease is the leading cause of death in women is wildly underappreciated, says the Brigham’s JoAnn E. Manson, MD, MPH, DrPH. Dr. Manson has led many seminal research projects focused on women’s health and set the foundation for related advances at the Brigham today.

Brigham and Women’s Hospital researchers conducted a patient-level meta-analysis of ACUITY plus four other large randomized trials. Bivalirudin was not associated with any significant difference in 30-day effectiveness outcomes compared with heparin, but had a substantially better safety profile.

On November 11—13, 2023, experts from the Brigham’s Heart and Vascular Center will join thousands of colleagues in raising awareness and improving cardiovascular health at this year’s American Heart Association (AHA) Scientific Sessions.

Cardiovascular experts from Brigham and Women’s Hospital will present at this year’s Transcatheter Cardiovascular Therapeutics (TCT) Conference on interventional cardiology, held October 23–26 in San Francisco, CA.

Using a novel method, Brigham and Women’s Hospital researchers completed the first comparative proteomics study of pathogenesis in calcified carotid arteries and aortic valves (AVs), identifying unique drivers of atherosclerosis versus AV stenosis and implicating extracellular vesicles in both diseases.